Despite today's fall in Pfizer's share price, it beat my and Wall Street analysts' expectations for the third quarter of 2024 by a large margin.Tafamidis franchise sales were $1.45 billion in Q3 2024,...
Source LinkDespite today's fall in Pfizer's share price, it beat my and Wall Street analysts' expectations for the third quarter of 2024 by a large margin.Tafamidis franchise sales were $1.45 billion in Q3 2024,...
Source Link
Comments